The U.S. Food and Drug Administration issued a Monday alert over five deaths related to intragastric balloons. Intragastric balloons—used in the treatment of obesity—have so far been linked to a dozen fatalities worldwide. A nominally invasive device, the balloons encourage weight loss by taking up space in a patient’s stomach. Inserted through an individual’s mouth,
Minnesota Files Lawsuit Against Drug Company for Pain Reliever
Multiple Small Illinois Towns File Lawsuit Against Drug Company
Doctor Lived “Lavish” Lifestyle from Unnecessary Treatments
F.D.A. Make Public Generic-Blocking Practices of Drug Companies
Azar Discusses Proposed Changes to Medicare Part B
More States Prepare to ‘Go to War’ Against Drug Companies
Six More States File Opioid Abuse Lawsuits Against Purdue Pharma
McKesson Executives Deposed Regarding West Virginia Opioid Crisis
DEA Announces Plan to Limit Production of Opioids